Chemerin antibody (AA 21-157)

Catalog No. ABIN7167807

Product Details anti-Chemerin Antibody

Target: Chemerin (RARRES2) (Retinoic Acid Receptor Responder (Tazarotene Induced) 2 (RARRES2))

Binding Specificity: AA 21-157

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This Chemerin antibody is un-conjugated

Application: Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)

Cross-Reactivity: Human

Purification: >95%, Protein G purified

Immunogen: Recombinant Human Retinoic acid receptor responder protein 2 protein (21-157AA)

Isotype: IgG

Application Details

Application Notes: Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C,-80 °C

Storage Comment: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Target Details for Chemerin

Target: Chemerin (RARRES2) (Retinoic Acid Receptor Responder (Tazarotene Induced) 2 (RARRES2))

Alternative Name: RARRES2 (RARRES2 Products)

Synonyms: HP10433 antibody, TIG2 antibody, 0610007L05Rik antibody, AI303516 antibody, retinoic acid receptor responder 2 antibody, retinoic acid receptor responder (tazarotene induced) 2 antibody, RARRES2 antibody, Rarres2 antibody

Background:

Background: Adipocyte-secreted protein (adipokine) that regulates adipogenesis, metabolism and inflammation through activation of the chemokine-like receptor 1 (CMKLR1). Its other ligands include G protein-coupled receptor 1 (GPR1) and chemokine receptor-like 2 (CCRL2). Positively regulates adipocyte differentiation, modulates the expression of adipocyte genes involved in lipid and glucose metabolism and might play a role in angiogenesis, a process essential for the expansion of white adipose tissue. Also acts as a proinflammatory adipokine, causing an increase in secretion of proinflammatory and prodiabetic adipokines, which further impair adipose tissue metabolic function and have negative systemic effects including impaired insulin sensitivity, altered glucose and lipid metabolism, and a decrease in vascular function in other tissues. Can have both pro- and anti-inflammatory properties depending on the modality of enzymatic cleavage by different classes of proteases. Acts as a chemotactic factor for leukocyte populations expressing CMKLR1, particularly immature plasmacytoid dendritic cells, but also immature myeloid DCs, macrophages and natural killer cells. Exerts an anti-inflammatory role by preventing TNF/TNFA-induced VCAM1 expression and monocytes adhesion in vascular endothelial cells. The effect is mediated via inhibiting activation of NF-kappa-B and CRK/p38 through stimulation of AKT1/NOS3 signaling and nitric oxide production. Its dual role in inflammation and metabolism might provide a link between chronic inflammation and obesity, as well as obesity-related disorders such as type 2 diabetes and cardiovascular disease. Exhibits an antimicrobial function in the skin.

Aliases: HP10433 antibody, RAR responsive protein TIG2 antibody, RAR-responsive protein TIG2 antibody, RARR2_HUMAN antibody, RARRES2 antibody, Retinoic acid receptor responder (tazarotene induced) 2 antibody, Retinoic acid receptor responder 2 antibody, Retinoic acid receptor responder protein 2 antibody, Tazarotene induced gene 2 protein antibody, Tazarotene-induced gene 2 protein antibody, TIG2 antibody

UniProt: Q99969

Pathways: Brown Fat Cell Differentiation